December 24, 20203 min read, 564 words
Published: December 24, 2020 | 3 min read, 564 words
By , ANKARA (Reuters) -A COVID-19 vaccine developed by China’s Sinovac Biotech is 91.25% effective, according to interim data from a late-stage trial in Turkey, a potentially much better result than reported from a separate trial of the vaccine in Brazil.Researchers in Brazil, wh...
CRITIC REVIEWS
There don't seem to be any reviews yet.
PUBLIC REVIEWS
There don't seem to be any reviews yet.